[HTML][HTML] Current knowledge about biomarkers of acute kidney injury in liver cirrhosis

HA Lee, YS Seo - Clinical and Molecular Hepatology, 2022 - ncbi.nlm.nih.gov
Acute kidney injury (AKI) is common in advanced cirrhosis. Prerenal azotemia, hepatorenal
syndrome, and acute tubular necrosis are the main causes of AKI in patients with cirrhosis …

Novel biomarkers of AKI in cirrhosis

A Juanola, AT Ma, E Pose… - Seminars in Liver Disease, 2022 - thieme-connect.com
Acute kidney injury (AKI) is a frequent complication in patients with cirrhosis that is
associated with poor outcomes and decreased survival. The definition of AKI in cirrhosis is …

[HTML][HTML] Acute kidney injury in liver cirrhosis: new definition and application

F Wong - Clinical and molecular hepatology, 2016 - ncbi.nlm.nih.gov
The traditional diagnostic criteria of renal dysfunction in cirrhosis are a 50% increase in
serum creatinine (SCr) with a final value above 1.5 mg/dL. This means that patients with …

Kidney damage biomarkers: Novel tools for the diagnostic assessment of acute kidney injury in cirrhosis

F Wong, P Murray - Hepatology, 2014 - journals.lww.com
Renal dysfunction is a common complication of liver cirrhosis, occurring in approximately
20% of all patients with cirrhosis admitted into hospital. 1 The majority of these cases are …

[HTML][HTML] Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis

SK Jo, J Yang, SM Hwang, MS Lee, SH Park - Scientific reports, 2019 - nature.com
Evidence suggests that novel biomarkers predict acute kidney injury (AKI) development and
outcome earlier than serum creatinine. The aim of this study was to determine the incidence …

Advances in the diagnosis and treatment of acute kidney injury in cirrhosis patients

L Lei, L Li, H Zhang - BioMed Research International, 2017 - Wiley Online Library
Liver cirrhosis is a common progressive and chronic clinical liver disease. Due to the strong
compensation ability of the liver, no obvious symptoms develop in the early stage. However …

Role of novel kidney biomarkers in patients with cirrhosis and after liver transplantation

SK Asrani, N Shankar, B da Graca… - Liver …, 2022 - Wiley Online Library
Acute kidney injury (AKI) and chronic kidney disease (CKD) are important drivers of
morbidity and mortality in patients with cirrhosis before and after liver transplantation (LT). In …

Acute kidney injury in liver disease: role of biomarkers

JM Belcher - Advances in Chronic Kidney Disease, 2015 - Elsevier
Acute kidney injury (AKI) is a common complication in patients with advanced cirrhosis and
is associated with significant mortality. The most common etiologies of AKI in this setting are …

[HTML][HTML] Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis

L Lei, LP Li, Z Zeng, JX Mu, X Yang, C Zhou… - Scientific reports, 2018 - nature.com
Urinary kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL),
and serum cystatin C (Cys C) are biomarkers of acute kidney injury (AKI). However, the …

The evolving concept of acute kidney injury in patients with cirrhosis

F Wong - Nature reviews Gastroenterology & hepatology, 2015 - nature.com
Renal dysfunction is prevalent in patients with advanced cirrhosis and decompensation. The
presence of type 1 hepatorenal syndrome (HRS) has traditionally been defined by a set of …